Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.05p
   
  • Change Today:
      0.050p
  • 52 Week High: 12.65
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 1,706,110
  • Market Cap: £21.26m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
47.4% below the market average47.4% below the market average47.4% below the market average47.4% below the market average47.4% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
32.01% below the market average32.01% below the market average32.01% below the market average32.01% below the market average32.01% below the market average
18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average18.18% below the sector average
Price Chg 3m
56.57% above the market average56.57% above the market average56.57% above the market average56.57% above the market average56.57% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
0.3% below the market average0.3% below the market average0.3% below the market average0.3% below the market average0.3% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Momentum 20
5.47% below the market average5.47% below the market average5.47% below the market average5.47% below the market average5.47% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
68.76% below the market average68.76% below the market average68.76% below the market average68.76% below the market average68.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average58.97% below the market average
38.1% below the sector average38.1% below the sector average38.1% below the sector average38.1% below the sector average38.1% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
79.52% below the market average79.52% below the market average79.52% below the market average79.52% below the market average79.52% below the market average
47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.28% below the market average35.28% below the market average35.28% below the market average35.28% below the market average35.28% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average
Cash
64.72% below the market average64.72% below the market average64.72% below the market average64.72% below the market average64.72% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
3.90% above the market average3.90% above the market average3.90% above the market average3.90% above the market average3.90% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.05p
Change Today 0.050p
% Change 1.67 %
52 Week High 12.65
52 Week Low 2.40
Volume 1,706,110
Shares Issued 697.20m
Market Cap £21.26m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 22-Aug-2025

Time Volume / Share Price
16:07 1,131 @ 3.05p
13:46 4,340 @ 3.00p
12:48 9,746 @ 3.08p
12:24 525,851 @ 2.96p
12:04 9,666 @ 2.97p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page